Bioservo and Eiffage strengthen RD- collaboration to develop the bionic arm « Ironarm »
Bioservo Technologies AB and the infrastructure division of Eiffage strengthen their cooperation to develop a bionic arm, one year after the development of “Ironhand® the bionic glove concept, the world’s first muscle-strengthening soft robotics system.
Bioservo’s SEM™ technology is well suited to prevent musculoskeletal disorders (MSD) caused by repetitive or strenuous tasks. The general idea behind Bioservo’s technology is to create a sustainable workplace and revolutionize manual labor. The purpose of “Ironarm” is to significantly reduce the impact of the constraints that can be caused in different manual work tasks.
Eiffage has already placed a first order to Bioservo, worth 87 000 euros for the development of “Ironarm”. A first prototype will be delivered at the end of the first quarter 2019 and will be followed by tests in the second quarter 2019.
“We were impressed by the results achieved during the test period conducted with the bionic glove in real work situations in different areas within the Group. A reduction or compensation between 25 to 82 % of the efforts of the workers was observed.
Bioservo’s SEM™ technology is well suited to prevent musculoskeletal disorders (MSD) and to encourage the employment of people with disabilities. We are going to strengthen our partnership with Bioservo to develop “Ironarm”, a solution that can reduce the impact of strenuous work on the full arm” explains Erick Lemonnier, Prevention Director at Eiffage’s Infrastructure Division.
“Our bionic SEM™ technology can be applied anywhere on the human body enhancing both strength and endurance. As a company, we have made a strategic decision to focus primarily on the upper body. That Eiffage Infrastructures has decided to expand the cooperation with us and that we will jointly push the development of our “Ironarm” concept is invaluable. This enables us to broaden our product portfolio with new products aligned with market demand”, says Petter Bäckgren, CEO of Bioservo Technologies.
About Bioservo Technologies AB
Bioservo Technologies (publ) is a technology and development company that combines medical science with modern robotics. Global leader within soft exoskeleton technology – wearable non-invasive devices
Founded in 2006 through a collaboration between researchers at the Royal Institute of Technology and doctors at Karolinska University Hospital in Stockholm. Bioservo Technologies is a Swedish public limited company with its headquarters and operations based in Kista, north of Stockholm.
About Eiffage
Eiffage is one of the European leaders in public works and concessions and operates in construction, real estate and development, across civil engineering, metal, roads, energy systems and concessions. The Group draws on the experience of more than 65,000 staff and in 2017 turned over 15 billion euros, 21 % of which was abroad.
Contact Press
Bioservo Technologies
Petter Bäckgren
CEO
Tel. : +46 (0)8 21 17 10
petter.backgren@bioservo.com
Anett Grusser-Pettersson
International Business Development
Eiffage
Dominique-Marie Duchemin
Director of Communication
Tel. : +33 1 71 59 17 10
Dominique-marie.duchemin@eiffage.com